Development of simple vaccine using vitamin D3 adjuvant
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
RIKENPrincipal Investigator
Unspecified Hidehiro FukuyamaResearch Location
JapanLead Research Institution
Laboratory for Lymphocyte Differentiation, Center for Integrative Medical SciencesResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Our goal is to establish a safe and simple vaccine for COVID-19. Herd immunity requires the global community to be immunized simultaneously. We will work to develop a needle-less vaccine system by taking an advantage of our new adjuvant discovered at RIKEN.